Annual General Meetings Archive

  • Shareholders of Clariant AG were invited to attend and participate in the Annual General Meeting (“AGM”) held on Thursday, April 21, 2016 at 10.30 am. The meeting was held at the Congress Center Basel, CH-4058 Basel, Switzerland.

    ANNUAL GENERAL MEETING 2016

    Clariant’s shareholders approve all agenda items at the Annual General Meeting

    • Distribution of CHF 0.40 per share confirmed
    • Annual Report and Group’s Consolidated Financial Statements for fiscal year 2015 approved
    • Shareholders approve Compensation Report 2015 on a consultative basis
    • Eveline Saupper, Claudia Suessmuth Dyckerhoff, and Peter Steiner newly elected as members of the Board of Directors 

    Muttenz, April 21, 2016 – At today’s Annual General Meeting in Basel, the shareholders of Clariant AG, a world leader in specialty chemicals, approved all agenda items and proposals put forward by the Board of Directors. The meeting was attended by 323 shareholders and shareholder representatives accounting for 188 389 574 shares or around 56.75 % of the share capital of Clariant.
    Hariolf Kottmann, CEO, reconfirmed the mid-term target to achieve a position in the top tier of the specialty chemicals industry. “This corresponds to an EBITDA margin range of 16 % to 19 % before exceptional items, and a return on invested capital (ROIC) above the peer group average”, said Hariolf Kottmann. “For 2016, in spite of the increasingly challenging economic environment, we are confident that we will achieve growth in local currencies, progression in EBITDA margin before exceptional items and improvements to operating cash flow.”

    At the Annual General Meeting, the Annual Report as well as the Group’s Consolidated Financial Statements for the fiscal year 2015 were approved with 99.96 % of the votes. The 2015 Compensation Report was also approved on a consultative basis with 88.19 % of the votes. The members of the Board of Directors and the Executive Committee were discharged with 99.41 % of the votes. In addition, the Annual General Meeting approved the appropriation of the accumulated profit for 2015 with 99.94 % of the votes, as well as a distribution of the confirmed reserves from capital contributions of CHF 0.40 per share with 99.94 % of the votes. 
    Nominated by the Board of Directors, Eveline Saupper (57), a Swiss citizen, Claudia Suessmuth Dyckerhoff (49), a German citizen, and Peter Steiner (56), a German citizen, were elected as board members. Peter R. Isler has reached the statutory maximum age for board members and will therefore resign. All other members of the Board of Directors were reelected for one year by a large majority, as was the Chairman of the Board of Directors, Rudolf Wehrli. PricewaterhouseCoopers Ltd was confirmed as the statutory auditor for 2016.

    The proposal for overall compensation of the Board of Directors for the term from the 2016 to the 2017 Annual General Meeting was approved with 98.85 % of the votes, as was the overall compensation of the Executive Committee for financial year 2017, with 90.15 % of the votes.
    Downloads

    Download File

    Please enter your contact details and the file will start downloading immediately after your details have been submitted. This only has to be done for the first file you download on this site. Thank you for your understanding.

    Personal Information

  • Shareholders of Clariant AG were invited to attend and participate in the Annual General Meeting (“AGM”) held on Tuesday, March 31, 2015 at 10.30 am. The meeting was held at the Congress Center Basel, CH-4058 Basel, Switzerland.

    ANNUAL GENERAL MEETING 2015

    Clariant’s Shareholders Approve All Agenda Items

    • Distribution increases to CHF 0.40 per share
    • Annual Report and Group’s Consolidated Financial Statements for fiscal year 2014 approved
    • Shareholders approve Compensation Report 2014 on a consultative basis
    • Susanne Wamsler newly elected as a member of the Board of Directors

    Muttenz, March 31, 2015 – At today’s Annual General Meeting in Basel, the shareholders of Clariant AG, a world leader in specialty chemicals, approved all agenda items and proposals put forward by the Board of Directors. The meeting was attended by 459 shareholders and shareholder representatives accounting for 189451802 shares or around 57.07 % of the share capital of Clariant.

    Hariolf Kottmann, CEO, reconfirmed the mid-term target to achieve a position in the top tier of the specialty chemicals industry. “This corresponds to an EBITDA margin range of 16% to 19% before exceptional items, and a return on invested capital (ROIC) above peer group average”, said Hariolf Kottmann. “For 2015, we expect low to mid-single digit sales growth in local currencies, an EBITDA margin before exceptional items above 2014, and a significantly increased generation of cash flow.”

    The Annual General Meeting approved the Annual Report as well as the Group’s Consolidated Financial Statements for the fiscal year 2014 with 99.96 % of the votes in favor. The 2014 Compensation Report was also approved on a consultative basis with 88.71 % of the votes. The members of the Board of Directors and the Executive Committee were discharged with 99.74 % of the votes. In addition, the Annual General Meeting approved the appropriation of the accumulated profit for 2014 with 99.97 % of the votes in favor, as well as the distribution of reserves from capital contributions of CHF 0.40 per share with 99.97 % of the votes.

    Nominated by the Board of Directors, Susanne Wamsler, a US citizen, was elected as the first female board member. She replaces Dolf Stockhausen who has reached the statutory maximum age for board members and will therefore resign. All other members of the Board of Directors were reelected for one year by a large majority, as was the Chairman of the Board of Directors, Rudolf Wehrli. PricewaterhouseCoopers AG was confirmed as the auditor for 2015.

    The proposal for overall compensation of the Board of Directors for the period between the 2015 and 2016 Annual General Meetings was approved with 92.73 % of the votes, as was the overall compensation of the Executive Committee for financial year 2016, with 90.45 % of the votes.

    Downloads

    Download File

    Please enter your contact details and the file will start downloading immediately after your details have been submitted. This only has to be done for the first file you download on this site. Thank you for your understanding.

    Personal Information

  • Shareholders in Clariant AG were invited to attend and participate in the Annual General Meeting (“AGM”) to be held on Monday, March 24, 2014 at 9.30 am. The meeting was held at the Congress Center Basel, CH-4058 Basel, Switzerland.

    ANNUAL GENERAL MEETING 2014

    CLARIANT SHAREHOLDERS APPROVE ALL AGENDA ITEMS

    • Distribution of CHF 0.36 per share from capital contribution reserves approved
    • 2013 Compensation Report approved on a consultative basis
    • All members of the Board of Directors reelected
    • Approval of all agenda items resulting from the early implementation of the Ordinance against Excessive Compensation (“OaEC”)


    Muttenz, March 24, 2014 – At today’s Annual General Meeting in Basel, the shareholders of Clariant AG, a world leader in specialty chemicals, approved all agenda items and proposals put forward by the Board of Directors. The meeting was attended by 516 shareholders and shareholder representatives accounting for 169 039 978 shares or around 51 % of the share capital of Clariant.

    Hariolf Kottmann, CEO, commented: “We expect full-year sales growth in local currencies in the low to mid-single-digit range and a further improvement in the EBITDA margin before exceptional items in 2014 compared to financial year 2013. We are maintaining our target to become one of the leading specialty chemicals companies by 2015.”

    The Annual General Meeting approved the Annual Report as well as the Group’s Consolidated Financial Statements for the financial year 2013 with 99.30 % of the votes in favor. The 2013 Compensation Report was also approved on a consultative basis with 79.61 % of the votes. The members of the Board of Directors and the Executive Committee were discharged with 97.52 % of the votes. In addition, the Annual General Meeting approved the appropriation of the accumulated profit for 2013 with 99.39 % of the votes in favor, as well as the distribution of reserves from capital contributions of CHF 0.36 per share with 99.43 % of the votes.

    All members of the Board of Directors were reelected for one year by a large majority, as was the Chairman of the Board of Directors, Rudolf Wehrli. PricewaterhouseCoopers AG was confirmed as the auditor for 2014.

    To ensure early implementation of the “OaEC”, Clariant’s Board of Directors proposed comprehensive changes to the Articles of Association to the Annual General Meeting, which were all approved by a majority.

    The proposal for overall compensation of the Board of Directors for the period between the 2014 and 2015 Annual General Meetings was approved with 81.86 % of the votes, as was the overall compensation of the Executive Committee for financial year 2015, with 82.26 % of the votes.

    Downloads

    Download File

    Please enter your contact details and the file will start downloading immediately after your details have been submitted. This only has to be done for the first file you download on this site. Thank you for your understanding.

    Personal Information

  • Shareholders in Clariant AG were invited to attend and participate in the Annual General Meeting (“AGM”) to be held on Tuesday, March 26, 2013 at 10.30 am. The meeting was held at The Congress Center Messe Basel, CHF-4058 Basel, Switzerland.

    ANNUAL GENERAL MEETING 2013

    CLARIANT SHAREHOLDERS APPROVE ALL AGENDA ITEMS

    • Distribution of CHF 0.33 per share from capital contribution reserves approved
    • Board member Prof. Peter Chen re-elected
    • 2012 Compensation Report approved on a consultative basis

    Muttenz, March 26, 2013 – Today's Annual General Meeting of Clariant AG – a world leader in specialty chemicals – in Basel was attended by 616 shareholders and representatives of shareholders, accounting for 155’858’480 shares or around 46.95% of the share capital of Clariant, who approved all of the items on the agenda.

    Hariolf Kottmann, CEO: "We expect full-year sales for the 2013 financial year to continue to grow as well as an increase in year-on-year profitability. We intend to generate additional growth by continuing to implement strategic initiatives and by increasing our focus on innovations. Recent investments will also contribute towards generating growth and increasing margins."

    The Annual General Meeting approved the Annual Report as well as the annual and consolidated financial statements for the 2012 financial year with 99.73% of the votes, discharged the Board of Directors and the Board of Management for their actions with 93.7% of the votes, and determined the appropriation of the profit accumulated in 2012 as well as the distribution of reserves from capital contributions with 99.79% of the votes. In addition, 71.81% of the votes were in favor of approving the company's 2012 Compensation Report on a consultative basis.

    Professor Peter Chen was re-elected as a member of the Board of Directors for a further three years.

    PricewaterhouseCoopers AG was re-elected as the auditor for 2013.

    Downloads

    Download File

    Please enter your contact details and the file will start downloading immediately after your details have been submitted. This only has to be done for the first file you download on this site. Thank you for your understanding.

    Personal Information

  • Shareholders in Clariant AG were invited to attend and participate in the Annual General Meeting ("AGM") on Thursday, March 31, 2011 at 10.30 am. The meeting was held at The Congress Center Messe Basel, CH-4058 Basel, Switzerland.

    ANNUAL GENERAL MEETING 2012

    CLARIANT SHAREHOLDERS APPROVE ALL AGENDA ITEMS

    • Dividend payment resumed at CHF 0.30 per share through reduction of par value
    • Waiving of voting rights limit of 10 percent of share capital
    • Clariant re-affirms Group outlook 2012
    • Rudolf Wehrli succeeds Jürg Witmer as Chairman of the Board of Directors

    Muttenz, March 27, 2012 - The Annual General Meeting of Clariant AG, a world leader in specialty chemicals, took place on 27 March 2012 in Basel and approved all agenda items. It was attended by 560 shareholders or proxies, representing 132`215`758 shares or 44.7% of Clariant’s total share capital.

    The AGM approved the annual report and annual accounts for 2011 with 99.9 percent of votes, discharged the corporate bodies of the company with 98.1 percent of votes, and voted for the allocation of the available net profit to the free reserves with 99.8 percent. With 76.8 percent of votes, it also approved on a consultative basis the company’s compensation policy.

    With 99.7 percent of votes, the General Meeting followed the Board of Director’s proposal to repay the par value of CHF 0.30 per registered share, instead of distributing an ordinary dividend. The share capital will therefore be reduced as well as the par value of each registered share by CHF 0.30 to CHF 3.70.

    With 65.6 percent of votes, shareholders also waived the restriction of the voting rights limit of 10 percent of the share capital for each shareholder.

    Rudolf Wehrli succeeded Jürg Witmer as Chairman of the Board of Directors, as both Witmer and Klaus Jenny retired from the Board.

    PricewaterhouseCoopers AG was re-elected as auditors for the financial year 2012.

    In his outlook, CEO Hariolf Kottmann confirmed the already announced expectations for 2012. An accurate forecast for 2012 is difficult to make, given the current level of economic uncertainty. In its base case scenario, Clariant expects that, after a weak start to 2012, the global economy will progressively strengthen in the course of the year. Therefore, results for the first half-year are expected to be lower compared to the high base of the first half of 2011, with an improvement in the second half-year 2012. For full-year 2012, Clariant expects further sales growth in local currencies and sustained profitability.

    Downloads

    Download File

    Please enter your contact details and the file will start downloading immediately after your details have been submitted. This only has to be done for the first file you download on this site. Thank you for your understanding.

    Personal Information


Request to Clariant

Please enter your contact information so we are able to process your request. Thank you for your interest.

Contact Us
Contact Us
Online Communications Team
Disclaimer:
This information corresponds to the present state of our knowledge and is intended as a general description of our products and their possible applications. Clariant makes no warranties, express or implied, as to the information’s accuracy, adequacy, sufficiency or freedom from defect and assumes no liability in connection with any use of this information. Any user of this product is responsible for determining the suitability of Clariant’s products for its particular application.<br />
<br />
* Nothing included in this information waives any of Clariant’s General Terms and Conditions of Sale, which control unless it agrees otherwise in writing. Any existing intellectual/industrial property rights must be observed. Due to possible changes in our products and applicable national and international regulations and laws, the status of our products could change. Material Safety Data Sheets providing safety precautions, that should be observed when handling or storing Clariant products, are available upon request and are provided in compliance with applicable law. You should obtain and review the applicable Material Safety Data Sheet information before handling any of these products. For additional information, please contact Clariant.<br />
<br />
* For sales to customers located within the United States and Canada the following applies in addition: No express or implied warranty is made of the merchantability, suitability, fitness for a particular purpose or otherwise of any product or service.<br />
<br />
© Trademark of Clariant registered in many countries.<br />
® 2019 Clariant International Ltd 

You are about to leave the Clariant domain

The link you activated will take you outside the Clariant site in about 10 seconds. If you want to stop this, press "Cancel".